it has already been a eventful week for nasdaq:tnxp with capital raise issues and a new pipeline drug candidate update. nest week could be equally important as on tuesday the company releases data on tnx-102 pharmacokintec . the stock is setting up nicely for the week to come. company profile tonix pharmaceuticals holding corp. is a clinical TNXP SEC Filings, 10K, 8K - Tonix Pharmaceuticals Holding TNXP / Tonix Pharmaceuticals Holding Corp. - 8-K - Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders 01-16 sec.gov Tonix Pharmaceuticals (TNXP) | The Biotech Investor Jun 21, 2016 · Market initially cheered the PTSD news where the dosage was found that produces statistically significant efficacy. Bad news was that it only lasted 30 minutes, as the conference call disclosed that two Phase 3 trials would be needed (1 for military PTSD and 1 for civilian) and that trial enrollment is expected to take 1 year after starting in early 2017.
3H8jbrNjJTpu6tZtFTHoCqCY7TnXp88F8K. A fabricated event will also cause stock market, supermarket runs, travel restrictions, shortages & everything that comes w it. All traders are taking about on stocktwits 'h41R5YaPiPG902tnXP2ZliG8Hn8AbcyS0Wqa9EKT4cY', 'OCAK',true,true, 'https:\/\/accounts.google.com\/o\/nocookie');